ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

Clinical trial NCT00490139 · COMPLETED

Trial details

NCT number: NCT00490139
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2007-05-16
Primary completion: 2013-12-06
Enrollment: 8381

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.